Arrowstreet Capital
DCPH

Arrowstreet Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Arrowstreet Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,407
Closed -$681K – 2573
2020
Q2 		$681K Buy
+11,407
New +$610K ﹤0.01% 1895

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital's DCPH Position: Q3 2020 in Review

Arrowstreet Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2020, closing a stake of 11,407 shares — an estimated $681K sold.

Arrowstreet Capital first reported a position in DCPH in Q2 2020 and held it in 1 quarter. The position peaked at $681K in Q2 2020. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2020.

  • Arrowstreet Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 11,407 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $681K.
  • Arrowstreet Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Arrowstreet Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $681K in Q2 2020.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.